These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 32742719)

  • 1. Safety and tolerability evaluation after repeated intravitreal injections of a humanized anti-VEGF-A monoclonal antibody (PRO-169) versus ranibizumab in New Zealand white rabbits.
    Baiza-Durán L; Sánchez-Ríos A; González-Barón J; Olvera-Montaño O; Correa-Gallegos E; Navarro-Sánchez A; Muñoz-Villegas P
    Int J Retina Vitreous; 2020; 6():32. PubMed ID: 32742719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety evaluation of repeated intravitreal injections of bevacizumab and ranibizumab in rabbit eyes.
    Zayit-Soudry S; Zemel E; Loewenstein A; Perlman I
    Retina; 2010 Apr; 30(4):671-81. PubMed ID: 19952984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preclinical safety evaluation of intravitreal injection of full-length humanized vascular endothelial growth factor antibody in rabbit eyes.
    Inan UU; Avci B; Kusbeci T; Kaderli B; Avci R; Temel SG
    Invest Ophthalmol Vis Sci; 2007 Apr; 48(4):1773-81. PubMed ID: 17389511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retinal function and morphology in rabbit after intravitreal injection of VEGF inhibitors.
    Myers AC; Lövestam Adrian M; Bruun A; Ghosh F; Andréasson S; Ponjavic V
    Curr Eye Res; 2012 May; 37(5):399-407. PubMed ID: 22510009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of vitreous clearance and potential retinal toxicity of intravitreal lornoxicam (xefo).
    Diakonis VF; Tsourdou A; Tzatzarakis MN; Tsika C; Charisis S; Naoumidi I; Plainis S; Tsilimbaris MK
    J Ocul Pharmacol Ther; 2013 Sep; 29(7):627-32. PubMed ID: 23556534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histological and Immunohistochemical Retinal Changes Following the Intravitreal Injection of Aflibercept, Bevacizumab and Ranibizumab in Newborn Rabbits.
    Cam D; Berk AT; Micili SC; Kume T; Ergur BU; Yilmaz O
    Curr Eye Res; 2017 Feb; 42(2):315-322. PubMed ID: 27314606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and Safety of an Intravitreal Humanized Anti-VEGF-A Monoclonal Antibody (PRO-169), a Biosimilar Candidate to Bevacizumab.
    Muñoz-Villegas P; Sanchez-Rios A; Quinonez-Alvarado MG; Olvera-Montaño O; Quintana-Hau JD; Baiza-Duran L
    J Exp Pharmacol; 2021; 13():545-554. PubMed ID: 34113182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety of intravitreal bevacizumab in the developing rabbit retina.
    Zayit-Soudry S; Zemel E; Barak A; Perlman I; Loewenstein A
    Retina; 2011 Oct; 31(9):1885-95. PubMed ID: 21799464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retinal toxicity of intravitreal trastuzumab in a rabbit model: preliminary results of an experimental study.
    Moschos MM; Chatziralli IP; Kalogeropoulos C; Georgountzos V; Agapitos E
    J Ocul Pharmacol Ther; 2013 Oct; 29(8):754-9. PubMed ID: 23597072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and retinal distribution of ranibizumab, a humanized antibody fragment directed against VEGF-A, following intravitreal administration in rabbits.
    Gaudreault J; Fei D; Beyer JC; Ryan A; Rangell L; Shiu V; Damico LA
    Retina; 2007; 27(9):1260-6. PubMed ID: 18046235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy of intravitreal injection of ranibizumab in combination with verteporfin PDT on experimental choroidal neovascularization in the monkey.
    Husain D; Kim I; Gauthier D; Lane AM; Tsilimbaris MK; Ezra E; Connolly EJ; Michaud N; Gragoudas ES; O'Neill CA; Beyer JC; Miller JW
    Arch Ophthalmol; 2005 Apr; 123(4):509-16. PubMed ID: 15824225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-vascular endothelial growth factor for macular oedema secondary to branch retinal vein occlusion.
    Mitry D; Bunce C; Charteris D
    Cochrane Database Syst Rev; 2013 Jan; (1):CD009510. PubMed ID: 23440840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravitreal injection of the synthetic peptide LyeTx I b, derived from a spider toxin, into the rabbit eye is safe and prevents neovascularization in a chorio-allantoic membrane model.
    Silva FRD; Paiva MRB; Dourado LFN; Silva RO; Silva CND; Costa BLD; Toledo CR; de Lima ME; Silva-Cunha AD
    J Venom Anim Toxins Incl Trop Dis; 2018; 24():31. PubMed ID: 30479614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-vascular endothelial growth factor for neovascular age-related macular degeneration.
    Solomon SD; Lindsley K; Vedula SS; Krzystolik MG; Hawkins BS
    Cochrane Database Syst Rev; 2014 Aug; 8(8):CD005139. PubMed ID: 25170575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety of intravitreal clindamycin in albino rabbit eyes.
    Habot-Wilner Z; Mazza O; Shahar J; Massarweh A; Mann I; Loewenstein A; Perlman I
    Doc Ophthalmol; 2017 Oct; 135(2):133-146. PubMed ID: 28744691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tolerability and efficacy of multiple escalating doses of ranibizumab (Lucentis) for neovascular age-related macular degeneration.
    Rosenfeld PJ; Heier JS; Hantsbarger G; Shams N
    Ophthalmology; 2006 Apr; 113(4):623.e1. PubMed ID: 16581423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An experimental study to evaluate safety/toxicity of intravitreal natalizumab.
    Chawla R; Nath M; Moksha L; Nag TC; Velpandian T
    Indian J Ophthalmol; 2018 Oct; 66(10):1441-1445. PubMed ID: 30249830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Local and systemic toxicity of intravitreal melphalan for vitreous seeding in retinoblastoma: a preclinical and clinical study.
    Francis JH; Schaiquevich P; Buitrago E; Del Sole MJ; Zapata G; Croxatto JO; Marr BP; Brodie SE; Berra A; Chantada GL; Abramson DH
    Ophthalmology; 2014 Sep; 121(9):1810-7. PubMed ID: 24819859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Posterior vitreous detachment with microplasmin alters the retinal penetration of intravitreal bevacizumab (Avastin) in rabbit eyes.
    Goldenberg DT; Giblin FJ; Cheng M; Chintala SK; Trese MT; Drenser KA; Ruby AJ
    Retina; 2011 Feb; 31(2):393-400. PubMed ID: 21099453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AN IN VIVO STUDY OF INTRAVITREAL RANIBIZUMAB FOLLOWING SUBRETINAL INOCULATION OF RB CELLS IN RABBITS EYES.
    Nor A; Diana T; Tengku FA; Sarina S; Khairy St S; Azhany Y; Nor Hayati O; Liza-Sharmini
    Cesk Slov Oftalmol; 2022; 78(3):112-120. PubMed ID: 35760582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.